These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1239098)

  • 1. The clot-forming ability of fibrinogen in solutions containing glucose and sorbitol.
    Einarsson R
    Thromb Res; 1975 Dec; 7(6):925-8. PubMed ID: 1239098
    [No Abstract]   [Full Text] [Related]  

  • 2. Alkaloids of tobacco and blood coagulation: effect of nicotine on thrombin and fibrinogen.
    Singh JM; Singh MD
    Clin Toxicol; 1975; 8(1):43-52. PubMed ID: 1137933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition of blood coagulation in vitro by protease of Pseudomonas aeruginosa].
    Scharmann W; Kraft W
    Blut; 1974 Feb; 28(2):90-9. PubMed ID: 4272950
    [No Abstract]   [Full Text] [Related]  

  • 4. The inactivation of hemostatic factors by hematin.
    Green D; Reynolds N; Klein J; Kohl H; Ts'ao CH
    J Lab Clin Med; 1983 Sep; 102(3):361-9. PubMed ID: 6411843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fibrinogen derivatives appearing in calf plasma after the action of thrombin and endotoxin].
    Benabid Y; Laurent M; Concord E; Suscillon M
    Pathol Biol (Paris); 1973 Nov; 21():Suppl:24-30. PubMed ID: 4587012
    [No Abstract]   [Full Text] [Related]  

  • 6. Polyethylene glycol 6,000 enhancement of the clotting of fibrinogen solutions in visual and mechanical assays.
    Fenton JW; Fasco MJ
    Thromb Res; 1974 Jun; 4(6):809-17. PubMed ID: 4858454
    [No Abstract]   [Full Text] [Related]  

  • 7. Isolation and characterization of the thrombin-like enzyme from Cryptelytrops purpureomaculatus venom.
    Tan NH
    Comp Biochem Physiol C Toxicol Pharmacol; 2010 Jan; 151(1):131-6. PubMed ID: 19770070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duvernoy's gland secretion of Philodryas patagoniensis from the northeast of Argentina: its effects on blood coagulation.
    Peichoto ME; Leiva LC; Guaimás Moya LE; Rey L; Acosta O
    Toxicon; 2005 Mar; 45(4):527-34. PubMed ID: 15733575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure of fibrinogen and thrombin to nitric oxide donor ProliNONOate affects fibrin clot properties.
    Helms CC; Kapadia S; Gilmore AC; Lu Z; Basu S; Kim-Shapiro DB
    Blood Coagul Fibrinolysis; 2017 Jul; 28(5):356-364. PubMed ID: 27755019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DIFFERENCES IN THE CLOTTING OF LAMPREY FIBRINOGEN BY LAMPREY AND BOVINE THROMBINS.
    DOOLITTLE RF
    Biochem J; 1965 Mar; 94(3):735-41. PubMed ID: 14340065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of the clotting curves of complex dynamic rigidity for fibrinogen-thrombin solutions.
    Kaibara M; Fukada E
    Biorheology; 1980; 17(3):255-9. PubMed ID: 7213992
    [No Abstract]   [Full Text] [Related]  

  • 12. [Participation of sialic acid residue in the fibrinogen-fibrin conversion by thrombin].
    Akihama S; Matsuda Y; Fukase T; Yamanaka A; Okude M
    Yakugaku Zasshi; 1995 Jul; 115(7):537-42. PubMed ID: 7562401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kinetics of inhibition of the action of thrombin by the fibrinopeptides formed during the clotting of fibrinogen.
    Silver A; Murray M
    Thromb Diath Haemorrh; 1966 Jul; 16(1):277-95. PubMed ID: 6011260
    [No Abstract]   [Full Text] [Related]  

  • 14. Clotting of fibrinogen. 2. Calorimetry of the reversal of the effect of calcium on clotting with thrombin and with ancrod.
    Mihalyi E; Donovan JW
    Biochemistry; 1985 Jul; 24(14):3443-8. PubMed ID: 3929831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of oral contraceptives on fibrin-clot stabilization.
    Shanberge JN; Tanaka K; Gruhl MC; Ikemori R; Inoshita K
    Ann N Y Acad Sci; 1972 Dec; 202():220-9. PubMed ID: 4508925
    [No Abstract]   [Full Text] [Related]  

  • 16. Partial reduction of bovine fibrinogen by some sulphydryl compounds.
    Budzyński AZ; Stahl M
    Biochim Biophys Acta; 1969 Mar; 175(2):282-9. PubMed ID: 4238074
    [No Abstract]   [Full Text] [Related]  

  • 17. An hepatic inhibitor of activated clotting factor X (Stuart).
    Deykin D; Cochios F; Mosher D
    Biochem Biophys Res Commun; 1969 Jan; 34(2):245-51. PubMed ID: 5796744
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the stability of bovine plasma factor V.
    Day WC; Barton PG
    Biochim Biophys Acta; 1971 Feb; 261(2):457-68. PubMed ID: 5169152
    [No Abstract]   [Full Text] [Related]  

  • 19. Profound effects of cardiopulmonary bypass priming solutions on the fibrin part of clot formation: an ex vivo evaluation using rotation thromboelastometry.
    Brinkman AC; Romijn JW; van Barneveld LJ; Greuters S; Veerhoek D; Vonk AB; Boer C
    J Cardiothorac Vasc Anesth; 2010 Jun; 24(3):422-6. PubMed ID: 20056447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vivo effect of fibrinogen and factor XIII on clot formation and fibrinolysis in Glanzmann's thrombasthenia.
    Shenkman B; Livnat T; Misgav M; Budnik I; Einav Y; Martinowitz U
    Platelets; 2012; 23(8):604-10. PubMed ID: 22273510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.